A female patient reports increased anxiety after starting lamotrigine 50 mg daily for three weeks; is this a side effect and how should it be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Increased Anxiety After Starting Lamotrigine: Assessment and Management

This is likely a recognized psychiatric side effect of lamotrigine, and you should consider discontinuing the medication or switching to an alternative treatment, particularly given the short duration of use (3 weeks) and the availability of more established anxiolytic options.

Understanding Lamotrigine and Anxiety

Lamotrigine is a mood stabilizer primarily indicated for bipolar disorder maintenance and epilepsy—it has no FDA approval for anxiety disorders 1. The evidence regarding lamotrigine's effects on anxiety is mixed and concerning:

Documented Psychiatric Side Effects

Lamotrigine can induce psychiatric symptoms including anxiety, agitation, and behavioral activation 2. A comprehensive review of psychiatric symptoms related to lamotrigine use documented that the drug can cause:

  • Affective switches
  • Acute psychotic episodes
  • Hallucinations
  • Anxiety and agitation 2

While some case reports suggest lamotrigine reduced anxiety in specific contexts (PTSD 3, comorbid epilepsy 4), these are isolated cases and do not represent the typical response pattern.

Critical Context: What Lamotrigine Is NOT

The available guidelines make clear that lamotrigine is not recommended for primary anxiety disorders 5, 6. In fact:

  • Guidelines on mood stabilizers note that anticonvulsants like lamotrigine "have generally not been associated with severe arrhythmia" but make no claims about anxiolytic efficacy 5
  • A systematic review of HIV-related neuropathic pain explicitly recommends NOT using lamotrigine, finding it ineffective even for pain-related anxiety 6
  • Pediatric anxiety guidelines extensively discuss SSRIs but never mention lamotrigine as a treatment option 7

Why This Patient's Anxiety Worsened

At 50 mg daily for 3 weeks, several mechanisms could explain increased anxiety:

  1. Direct psychiatric side effect: Lamotrigine can cause behavioral activation/agitation, particularly early in treatment 2
  2. Lack of anxiolytic properties: Unlike SSRIs (which have robust evidence for anxiety 7), lamotrigine has no established anti-anxiety mechanism
  3. Dose-related effects: Even therapeutic doses can induce psychiatric symptoms 2

Recommended Management Algorithm

Immediate Steps:

  1. Verify the indication: Why was lamotrigine prescribed? If for anxiety alone, this is off-label and not evidence-based
  2. Assess severity: Is the anxiety causing functional impairment or distress requiring urgent intervention?
  3. Rule out other causes: Medication interactions, substance use, thyroid dysfunction, or caffeine intake

Treatment Decision:

For primary anxiety disorders, discontinue lamotrigine and initiate evidence-based treatment:

  • First-line pharmacotherapy: SSRIs (sertraline, escitalopram, or fluoxetine) have strong evidence for anxiety disorders 7

    • Start with low "test doses" as SSRIs themselves can initially cause anxiety 7
    • Titrate slowly over 1-2 weeks for short half-life SSRIs 7
    • Monitor closely in first weeks for behavioral activation 7

  • Optimal approach: Combination of CBT plus SSRI shows superior outcomes compared to either alone 7

Lamotrigine Discontinuation:

Since the patient has only been on 50 mg for 3 weeks, taper is less critical than with longer-term use, but consider reducing by 25 mg every 3-7 days to minimize any withdrawal effects.

Critical Caveats

If lamotrigine was prescribed for bipolar disorder (not mentioned in your question), the situation changes:

  • Lamotrigine is effective for bipolar depression 8, 9
  • However, it can induce mania in vulnerable populations, particularly those with bipolar I disorder, manic predominant polarity, or history of antidepressant-induced switches 10
  • Even in bipolar disorder, lamotrigine-induced anxiety would warrant dose adjustment or augmentation with an antimanic agent

Do not continue lamotrigine for anxiety symptoms alone—there is no evidence supporting this use, and the patient's worsening symptoms suggest harm rather than benefit. Switch to evidence-based anxiolytic treatment (SSRI ± CBT) 7.

References

7
Guideline

clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.

Journal of the American Academy of Child and Adolescent Psychiatry, 2020

Related Questions

What management advice should I give a patient with anxiety and three‑week mood instability who has been started on lamotrigine 50 mg, hydroxyzine, and trazodone, whose relative reports no improvement and who continues to use marijuana?
What are the recommended management steps for a patient with anxiety and mood instability who is taking lamotrigine but is dissatisfied with the medication?
In a patient taking lamotrigine 100 mg who is experiencing depressive symptoms, what antidepressant would be an appropriate add‑on?
Should a patient with a history of psychiatric illness, who has responded to an SSRI increase and shown no difference with a Lamotrigine reduction from 200mg to 100mg, taper off Lamotrigine?
What's the next step for a homeless female with abdominal pain, on Trulicity (dulaglutide) and LTG (lamotrigine), with a history of seizures, type 2 diabetes, hyperlipidemia, hypothyroidism, major depressive disorder, anxiety, and daily alcohol use?
When is metformin contraindicated in the management of diabetes mellitus?
Should a patient be diagnosed with panic disorder if they do not meet at least four DSM‑5 panic‑attack criteria, despite a Panic Disorder Severity Scale (PDSS) score of 28?
What diagnostic evaluation and management are recommended for a 37-year-old man with an 11-month history of epigastric pain that worsens on an empty stomach, prior treated Helicobacter pylori infection, lack of response to proton‑pump inhibitor (PPI) therapy, fatigue, occasional leg cramps, loose foul‑smelling stools, halitosis, cholecystectomy two months ago, pre‑diabetes (hemoglobin A1c in the pre‑diabetic range), and vitamin D insufficiency, with normal abdominal computed tomography (CT) and ultrasound (US)?
What are examples of medications commonly prescribed on an every‑8‑hour (q8hr) schedule?
Which clinician is responsible for managing a fracture of the proximal humerus at the surgical neck?
In a patient with intact continence who experiences an unpleasant sensation that disrupts sleep and quality of life, is this due to guarding or a sensory disturbance?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question